Long Noncoding RNA LINP1: Scaffolding Non-Homologous End Joining
A Sakthianandeswaren,S Liu,OM Sieber
DOI: https://doi.org/10.1038/cddiscovery.2016.59
2016-01-01
Cell Death Discovery
Abstract:Non-homologous end joining (NHEJ) is a principal pathway of DNA double-strand break (DSB) repair in mammalian cells, 1 but is also involved in assembly of antigen receptor genes and telomere maintenance. 2,3Loss of NHEJ function can result in chromosome instability promoting malignant transformation, in particular when other cellular safeguards are compromised.Inherited NHEJ defects underlie radiosensitive severe combined immunodeficiency.NHEJ is initiated by binding of Ku70-Ku80 heterodimers to both ends of a DNA break, followed by recruitment of catalytic subunits of DNAdependent protein kinase (DNA-PKcs) to form juxtaposed DNA-PK holoenzymes which join the ends in a synaptic complex.Cohesive blunt DNA ends can be joined directly by the XFL-XRCC4-DNA ligase IV complex, but in many cases DNA ends contain damaged bases or DNA backbone sugars that require processing before ligation.End processing may involve nucleases such as Artemis, DNA polymerases and polynucleotide kinase among other enzymes. 4,5n Nature Structural & Molecular Biology, Zhang et al. 6 recently reported the discovery of a long noncoding RNA (lncRNA) termed lncRNA in non-homologous end joining (NHEJ) pathway 1 (LINP1), that serves as an RNA scaffold interacting with Ku70-Ku80 and DNA-PKcs, promoting NHEJ repair (Figure 1).LINP1 was identified as overexpressed in triple-negative breast cancers (TNBCs) when compared with other breast cancer subtypes using RNA-seq data from The Cancer Genome Atlas and the Cancer Cell Line Encyclopedia (CCLE).LINP1 knockdown enhanced apoptosis in TNBC cell lines following doxorubicin treatment, a chemotherapy drug for TNBC, while overexpression of LINP1 in an estrogen-receptor positive breast cancer (ER+ BC) cell line with undetectable LINP1 protected these cells from doxorubicin-induced apoptosis.Using RNA pull-down, CHART and RNA-IP assays, Zhang et al. 6 demonstrated that LINP1 interacted with Ku70-Ku80 and DNA-PKcs.Specifically, LINP1 transcript bound to Ku80 via its 5′ region, and to DNA-PKcs via its 3′ region.LINP1 knockdown in TNBC cells resulted in reduced DNA break repair in comet, γ-H2AX foci and NHEJ reporter assays.Conversely, overexpression of LINP1 in ER+ BC cells increased NHEJ activity.Analyses of chromatin-associated NHEJ complexes post-irradiation with LINP1, Ku80 or DNA-PKcs knockdown indicated that recognition of DSBs by Ku70-Ku80 resulted in recruitment of LINP1 and DNA-PKcs, with LINP1 enhancing the Ku80-DNA-PKcs interaction.It will be interesting to determine the protein domains in Ku80 and DNA-PKcs mediating LINP1 interaction, whether LINP1 binding is regulated by or affects post-translational modifications and conformation states of Ku70-Ku80 or DNA-PKcs, and to what extent this impacts on other NHEJ components.EGF signaling was identified as a positive regulator of LINP1 expression.LINP1 levels were correlated with EGFR expression in primary breast cancers and CCLE cell lines.In CCLE cell lines, LINP1 expression was associated with the EGF downstream transcription factors c-Jun and c-Fox (both AP1 transcription factors), suggesting regulation via the RAS-MEK-JNK pathway.Accordingly, EGF treatment induced LINP1 in TNBC cells, but not in ER+ BC cells and LINP1 expression in TNBC cell lines could be repressed with EGFR, MEK and JNK inhibitors.ENCODE ChIP-seq data indicated enrichment of c-Jun or c-Fos at the LINP1